Wild 2018.
Study name |
Public title: A study of resilience training for student paramedics Scientific title: Preventing PTSD, depression, and associated health problems in student paramedics: a randomised controlled trial of internet‐delivered cognitive training for resilience (iCT‐R) |
Methods |
Study design: RCT Study grouping: parallel group Unit of randomisation: individuals Power (power sample size calculation, level of power achieved): Setting power at 80%, α = 0.05 and hypothesising a reduction of relative risk of 50% gives an Odds Ratio of 0.429, which requires a total sample size of 304 to show a risk reduction of 50% between internet‐delivered cognitive training for resilience (iCT‐R) and the alternative intervention. Thus, each condition would require 152 participants. Since we have a third condition (standard practice), the total sample size required would be 456. Allowing for a 20% rate of attrition, we will require a total sample size of 570 Imputation of missing data: potential method of imputation not specified; data analysis will be intention‐to‐treat; all participants who have been randomised will be included in analyses, including those who drop out |
Participants |
Country: UK Setting: online interventions Age: not specified in trial registration or study protocol Sample size (randomised): 570 targeted Sex: not specified Comorbidity (mean (SD) of respective measures in indicated, if available) at baseline: not specified Population description: student paramedics Inclusion criteria: see trial registration and study protocol (Wild 2018): 1) aged 18 and above (until 65 years); 2) training to be paramedics and in years 1, 2 or 3 of student paramedic training; 3) access to internet; 4) willing to be randomly allocated Exclusion criteria: see trial registration and study protocol (Wild 2018): 1) current symptoms of PTSD or MD, including suicidal ideation, requiring treatment (participants excluded if symptoms are interfering with their lives and they would like treatment; (score ≥ 10 on PHQ‐9); score on PHQ‐9 suicidal ideation item ≥ 1; Post‐traumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders, 5th edition (PCL‐5): ≥ 33) Attrition (withdrawals and exclusions): not specified Reasons for missing data: not specified |
Interventions |
Intervention: iCT‐R: n randomised not specified)
Control 1: attention control mind‐online resilience intervention (already available intervention; n randomised not specified)
Control 2: TAU/wait‐list control (n randomised not specified)
|
Outcomes |
Outcomes collected and reported: Primary outcome:
Secondary outcomes:
Tertiary outcomes (see study protocol Wild 2018):
Outcomes reported not specified Time points measured and reported: 1) pre‐intervention; 2) post‐intervention (i.e. 6 weeks); 3) 6‐month follow‐up (i.e. 6 months after intervention); 4) 1‐year follow‐up (i.e. 1 year after intervention); 5) 2‐year follow‐up (i.e. 2 years after intervention); diagnoses of PTSD and MD: all outcomes except 6‐month follow‐up; PTSD and MD symptomatology: all time points; secondary and tertiary outcomes: all time points except 6‐month follow‐up except for demographics (only pre‐intervention, 1‐year and 2‐year follow‐up); time points reported not specified Adverse events: not specified |
Starting date | Study start/end date: January 2016; ‐January 2021 |
Contact information |
Principal investigator: Dr Jennifer Wild Address: Department of Experimental Psychology; University of Oxford; Oxford Centre for Anxiety Disorders and Trauma, Oxford OX1 1TW, United Kingdom Email: jennifer.wild@psy.ox.ac.uk Telephone: +44 1865 618 612 |
Notes |
Contact with authors: no correspondence required Funding source:
Declaration of interest: see study protocol (Wild 2018): Jennifer Wild, Anke Ehlers and their team have developed iCT‐R. They do not receive any income from this work Ethical approval needed/obtained for study: Ethical approval of the research protocol was gained from The Medical Sciences Inter‐Divisional Research Ethics Committee at the University of Oxford, 17 August 2017, ref: R44116/RE001 Comments by study authors: trial registration number ISRCTN16493616 (assigned 9 October 2017) Miscellaneous outcomes by the review authors: according to trial registration, the study is no longer recruiting but the overall trial status is ongoing; intention to publish September 2021 (last updated October 2017) |
Abbreviations common to all tables:
α: significance level; β: statistical power; BADS: Behavioural Activation for Depression Scale; BASS: Beliefs About Stress Scales; BDI: Beck Depression Inventory; BMI: body mass index; BRS: Brief Resilience Scale; CD‐RISC: Connor‐Davidson Resilience Scale; CEQ: Capability and Expectancy Questionnaire; CES‐D: Center for Epidemiology Studies‐ Depression; CG: control group; d: delta (Cohen's d, effect size); IG: intervention group; GAD‐7: Generalised Anxiety Disorder scale; GHQ: General Health Questionnaire; iCT‐R: internet‐delivered cognitive training for resilience; ISI: Insomnia Severity Index; ITT: intention‐to‐treat analysis; MBI: Maslach Burnout Inventory; MBSR: mindfulness‐based stress reduction; MD: major depression; n: sample size (e.g. in respective study group); OBI: Oldenburg Burnout Inventory; PCL‐5: Post‐traumatic stress disorder Check List for Diagnostic and Statistical Manual of Mental Disorders, 5th Edition; PHQ: Patient Health Questionnaire; PSS: Perceived Stress Scale; PSS: Presenteeism Scale for Students; PTSD: post‐traumatic stress disorder; RCT: randomised controlled trial; RIQ: Response to Intrusions Scale; RRS: Ruminative Response Scale; RS: Resilience Scale; RSES: Rosenburg Self‐Esteem Scale; SCS: Self‐Compassion Scale; SD: standard deviation; SMS: short message service; STAI: State‐Trait Anxiety Inventory; TAU: Treatment as usual; VAS: Visual Analogue Scales; vs: versus; WEMWS: Warwick‐Edinburgh Mental Well‐being Scale